Diabetes Treatment and Management

59 та иш

Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan
Anna Alieva, Anvar Alimov, Feruza Khaidarova +5
МақолаDiabetes, Cardiovascular Risks, and LipoproteinsInternational Journal of Endocrinology and Metabolism20222 иқтибос
ABI
PS 14-53 COMPARISON OF TWO COMBINED ANTIHYPERTENSIVE THERAPY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME
Jamol Uzokov, Anis Alyavi, Bekzod Karimov +1
МақолаPharmacology and Obesity TreatmentJournal of Hypertension20161 иқтибос
ABI
Еvaluation the functional reserve of the kidneys in patients with chronic heart failure who have had the COVID-19 infection
A. G. Gadaev, Р. И. Туракулов, Нигора Пирматова +1
МақолаDiabetes Treatment and ManagementNephrology (Saint-Petersburg)20221 иқтибос
ABI
Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity
Ashot Avagimyan, А. И. Трофименко, Mohammad Sheibani +11
МақолаChemotherapy-induced cardiotoxicity and mitigationInnovative medicine of Kuban20231 иқтибос
ABI
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко +15
МақолаDiabetes Treatment and ManagementInnovative medicine of Kuban20241 иқтибос
ABI
Prediction of glycosylated hemoglobin level in patients with cardiovascular diseases and type 2 diabetes mellitus with respect to anti-diabetic medication
Alisher Ikramov, Shakhnoza Mukhtarova, Раиса Тригулова +2
МақолаDiabetes Treatment and ManagementFrontiers in Endocrinology20241 иқтибос
ABI
Searching for Hidden Patterns That Affect the Overall Patient Survival with Data Mining
Н. А. Игнатьев, E. N. Zguralskaya, M. V. Markovtseva
МақолаChronic Lymphocytic Leukemia ResearchScientific and Technical Information Processing20211 иқтибос
ABI
Influence of variability in risk factors on cardiovascular disease outcomes in type 2 diabetes mellitus
Jamol Uzokov
БошқаDiabetes, Cardiovascular Risks, and LipoproteinsEuropean Journal of Preventive Cardiology20231 иқтибос
ABI
Kurkumin kann Diabetes verhinderng
Beate Schumacher
МақолаDiabetes Treatment and ManagementCardioVasc20120 иқтибос
ABI
Kurkumin verhindert Diabetes
МақолаDiabetes Treatment and ManagementCME20120 иқтибос
ABI
Isoglycyrol
Shakhnoza S. Azimova, Valentina I. Vinogradova
БобDiabetic Foot Ulcer Assessment and Management20120 иқтибос
ABI
Kaladasterone
Shakhnoza S. Azimova
БобApelin-related biomedical research20120 иқтибос
ABI
Hygroline
Shakhnoza S. Azimova, Marat S. Yunusov
БобPharmacology and Obesity Treatment20120 иқтибос
ABI
Features of Genetic Polymorphism in Population with Diabetic Nephropathia: Literature Review
O. O. Jabborov
МақолаGenetic Associations and EpidemiologyJournal of Advances in Medicine and Medical Research20190 иқтибос
ABI
Nephroprotective Effects of 2nd Type Sodium-Glucose Co-Transporter Inhibitors: A Literature Review
Botir Daminov
Шарҳ мақолаDiabetes Treatment and ManagementIndian Journal of Forensic Medicine & Toxicology20200 иқтибос
ABI
Influence Of Different Hypoglycemic Therapy Schemes On Carbohydrate Exchange Indicators In Type 2 Diabetes Mellitus
Said Ismailov, Sitora Muminova
МақолаDiabetes Treatment and ManagementThe American Journal of Medical Sciences and Pharmaceutical Research20210 иқтибос
ABI
The value of the Left Ventricular Emission Fraction in Patients with Ischaemic Heart Disease with Diabetes Mellitus 2 in the Assessment of the Effectiveness of Sitagliptin/Metformin
Раиса Тригулова, Dilnoza Alimova, N.F. Tashkenbaeva +4
МақолаDiabetes Treatment and ManagementAmerican Heart Journal20210 иқтибос
ABI
The Relationship Between Glycemia and Heart Failure in Patients with Coronary Heart Disease and Diabetes Mellitus 2
Раиса Тригулова, N.F. Tashkenbaeva, F.M. Bekmetova +4
МақолаCardiovascular Function and Risk FactorsAmerican Heart Journal20210 иқтибос
ABI
Overview of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors for the Treatment of Non-diabetic Heart Failure Patients
Irina Balan, Tetyana Khayo, Sevara Sultanova +1
Шарҳ мақолаDiabetes Treatment and ManagementCureus20210 иқтибос
ABI
MO634: Effects of Dapagliflozin in Patients with Heart Failure
Sherzod Abdullaev, Olimkhon Sharapov
МақолаDiabetes Treatment and ManagementNephrology Dialysis Transplantation20220 иқтибос
ABI
Relationships Between the Achieved Target Levels of LDL Cholesterol and the State of Various Types of LV EF in Patients with Coronary Artery Disease and Type 2 Diabetes
Mukharram A Musaeva
МақолаDiabetes Treatment and ManagementINTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH AND ANALYSIS20220 иқтибос
ABI
Effects of SGLT2 Inhibitors on Rest Myocardial Perfusion in Patients with Type 2 Diabetes and Diabetic Nephropathy
Nodira Alikhanova, Charos Musakhanova, Nozimakhon Nazarova +6
МақолаDiabetes Treatment and ManagementAmerican Heart Journal20230 иқтибос
ABI
Influence of dapagliflozin on lipid parameters in patients with coronary artery disease and type 2 diabetes mellitus
Z. Ubaydullaeva, A. L. Alyavi, Jamol Uzokov +1
МақолаDiabetes Treatment and ManagementAtherosclerosis20230 иқтибос
ABI
МЕДИКО-СОЦИАЛЬНЫЕ АСПЕКТЫ ПРОБЛЕМЫ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ МОРБИДНОГО ОЖИРЕНИЯ (Обзор литературы)
Акрам Ботиров, Муроджон Расулов
МақолаBariatric Surgery and OutcomesMedical science of Uzbekistan20230 иқтибос
ABI
#3015 EFFECT OF DAPAGLIFLOZIN ON ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CKD
Sherzod Abdullaev, Olimkhon Sharapov
МақолаDiabetes Treatment and ManagementNephrology Dialysis Transplantation20230 иқтибос
ABI